Propel Bio Management’s TScan Therapeutics TCRX Stock Holding History

Propel Bio Management’s Portfolio TCRX Stock Details TCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$3.03M	Hold
2025 Q1	$2.88M	Hold
2024 Q4	$6.34M	Hold
2024 Q3	$10.4M	Hold
2024 Q2	$12.2M	Hold
2024 Q1	$16.6M	Hold
2023 Q4	$12.2M	Buy